This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
Requires pharmacies that stock FDA-approved or authorized contraceptives or related drugs to provide those items to customers immediately when in stock, and to promptly help customers get them when out of stock. Prohibits intimidation, refusal, misrepresentation, confidentiality breaches, or withholding valid prescriptions related to contraception, creates civil penalties and a private right of action, and becomes effective 31 days after enactment.
The bill strengthens contraceptive access, privacy, and enforcement—expanding coverage and immediate availability—but increases regulatory enforcement and compliance costs and limits some conscience defenses, which may create legal and access gaps for certain pharmacies and low-income or rural communities.
About 58 million people with private insurance will have FDA-approved contraceptives covered without cost-sharing, lowering out-of-pocket costs for birth control.
People seeking contraception can obtain in-stock contraceptives immediately or be assisted with locating/transferring prescriptions, improving timely access and reducing delays in care.
Recognition of FDA approvals and over-the-counter availability (including the 2023 OTC daily pill) expands access by enabling pharmacy or retail purchase without a prescription.
Pharmacies and businesses could face fines up to $100,000 per enforcement proceeding and other civil penalties, creating large compliance costs that may be passed to customers.
Expanded OTC access, coverage mandates, and enforcement could raise federal/state spending and regulatory burdens on insurers and pharmacies.
Limits on religious or moral-conscience defenses (e.g., restricting RFRA defenses) reduce legal protections available to employees and pharmacies with moral objections, risking conflict and litigation.
Introduced July 16, 2025 by Cory Anthony Booker · Last progress July 16, 2025